论文部分内容阅读
目的 :观察青蒿琥酯注射液治疗恶性疟疾的临床疗效。方法 :用青蒿琥酯注射液静脉推注治疗恶性疟疾 5 4例 ,用复方奎方 ( Quinimax)注射液静脉滴注治疗 46例。结果 :青蒿琥酯组有效率96.3% ,疟原虫转阴率 94.4% ;复方奎方组有效率 90 .3% ,疟原虫转阴率 91 .3%。两组比较 ,P<0 .0 5。结论 :青蒿琥酯和复方奎方均能治疗恶性疟疾 ,通过对疟原虫无性体强力的杀灭作用 ,能迅速控制症状和杀灭疟原虫。但青蒿琥酯比复方奎方疗效似更好 ,副作用少。
Objective: To observe the clinical efficacy of artesunate injection in the treatment of falciparum malaria. Methods: 54 cases of malignant malaria were treated with artesunate injection by intravenous injection, and 46 cases were treated by Quinimax injection. Results: The effective rate of artesunate group was 96.3% and that of parasite was 94.4%. The effective rate was 90.3% in compound Kuifang group and 91.3% in malaria group. The two groups, P <0. CONCLUSIONS: Artesunate and trimethoprim can both treat falciparum malaria and can rapidly control the symptoms and kill the parasite through powerful killing of asexual malaria parasites. However, artesunate than compound Kui Fang effect is better, less side effects.